Trump's 100% Tariff on Australian Drugs May Exempt CSL

Former US President Donald Trump imposes a 100 per cent tariff on Australian drugs, but CSL, Australia's largest biotech firm, may be exempt under specific conditions. The tariffs will not apply to therapies derived from blood plasma in certain circumstances, potentially mitigating the impact on CSL's operations.

Read the full story at Sydney Morning Herald→